Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityFed Funds SoldGoodwillGoodwill & IntangiblesInterest DepositsLiabilities and Shareholders EquityLoans - GrossLoans - Loss AllowanceLoans - NetNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemung Financial (CHMG) Cash & Equivalents: 2016-2025

Historic Cash & Equivalents for Chemung Financial (CHMG) over the last 10 years, with Sep 2025 value amounting to $107.6 million.

  • Chemung Financial's Cash & Equivalents rose 33.82% to $107.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.6 million, marking a year-over-year increase of 33.82%. This contributed to the annual value of $47.0 million for FY2024, which is 27.65% up from last year.
  • According to the latest figures from Q3 2025, Chemung Financial's Cash & Equivalents is $107.6 million, which was down 66.37% from $320.1 million recorded in Q2 2025.
  • In the past 5 years, Chemung Financial's Cash & Equivalents ranged from a high of $320.1 million in Q2 2025 and a low of $2.5 million during Q4 2021.
  • Over the past 3 years, Chemung Financial's median Cash & Equivalents value was $70.2 million (recorded in 2024), while the average stood at $88.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first slumped by 63.40% in 2021, then surged by 1,260.67% in 2023.
  • Chemung Financial's Cash & Equivalents (Quarterly) stood at $2.5 million in 2021, then increased by 9.50% to $2.7 million in 2022, then surged by 1,260.67% to $36.8 million in 2023, then climbed by 27.65% to $47.0 million in 2024, then soared by 33.82% to $107.6 million in 2025.
  • Its Cash & Equivalents stands at $107.6 million for Q3 2025, versus $320.1 million for Q2 2025 and $53.4 million for Q1 2025.